Table 3.

BV-TMEM and LV-TMEM scores in the non-distant metastatic and distant metastatic patient cohort.

Non Metastatic Cohort				Metastatic Cohort
Patient ID	Breast cancer Subtype	BV-TMEM	LV-TMEM	Patient ID	Breast cancer Subtype	BV-TMEM	LV-TMEM
1	L	12	0	31	L	13	0
2	L	10	0	32	L	31	0
3	L	8	0	33	L	31	0
4	L	7	0	34	L	16	0
5	L	35	0	35	L	33	0
6	L	20	0	36	L	19	0
7	TNBC	51	0	37	TNBC	65	0
8	HER2	14	0	38	HER2	63	0
9	L	42	0	39	L	39	0
10	HER2	16	1	40	HER2	46	0
11	L	34	0	41	L	38	0
12	L	34	0	42	L	72	0
13	HER2	74	0	43	TNBC	61	0
14	L	17	0	44	L	90	0
15	TNBC	17	0	45	TNBC	33	2
16	TNBC	25	0	46	HER2	20	0
17	HER2	13	0	47	TNBC	35	0
18	TNBC	46	0	48	TNBC	45	0
19	L	16	0	49	L	95	0
20	HER2	30	0	50	HER2	91	0
21	L	32	0	51	L	40	0
22	L	6	0	52	L	105	0
23	L	36	0	53	L	59	0
24	L	48	0	54	L	59	0
25	L	27	0	55	L	27	0
26	L	24	0	56	L	128	0
27	L	18	0	57	L	72	0
28	L	26	0	58	L	102	0
29	L	58	0	59	L	82	0
30	L	30	0	60	L	83	0

Abbreviations: BV, blood vessel; LV, lymphatic vessel; TMEM, tumor microenvironment of metastasis; L, luminal breast cancer; HER2, human epidermal growth factor receptor 2-enriched breast cancer; TNBC, triple-negative breast cancer.